Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sphingosine 1-phosphate receptor subtype 1 (S1PR1) is a G protein-coupled receptor (GPCR) that plays a central role in vascular biology and immune system regulation. It regulates endothelial cell cytoskeletal structure, migration, capillary-like network formation, and vascular maturation. It also controls lymphocyte maturation, migration, trafficking—especially egress of T and B cells from thymus and secondary lymphoid tissues. Furthermore, it maintains vascular integrity and acts as mechanotransduction signaling in response to blood flow. Several drugs targeting this axis are approved/under development for autoimmune diseases such as multiple sclerosis (e.g., fingolimod), inflammatory bowel disease; preclinical evidence supports potential benefit in lupus erythematosus, rheumatoid arthritis, systemic sclerosis.
Agonists mimic endogenous ligand effects; antagonists block them—both classes modulate immune responses via this pathway
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sphingosine 1-phosphate receptor subtype 1 (S1PR1).